LIVEPERSON INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation
Loss on disposal
Amortization of tenant allowance
Depreciation and amortization
Reduction of operating lease right-of-use assets
Amortization of purchased intangible assets and finance leases
Amortization of finance leases
Amortization of debt issuance costs and accretion of debt discount
Accretion of debt discount on convertible senior notes
Impairment of goodwill
Impairment of intangibles and other assets
Change in fair value of Warrants
Change in fair value of contingent consideration
Gain on troubled debt restructuring
Gain on debt extinguishment
Paid-in-Kind Interest
Allowance for credit losses
Loss (gain) on divestiture
Gain on settlement of leases
Deferred income taxes
Equity loss in joint venture
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Contract acquisition costs
Other assets
Accounts payable
Accounts payable, accrued expenses and other current liabilities
Deferred revenue
Operating lease liabilities
Other liabilities

Net cash used in operating activities
INVESTING ACTIVITIES:
Purchases of property and equipment, including capitalized internal-use software development costs
Proceeds from divestiture
Payments for acquisitions, net of cash acquired
Purchases of intangible assets
Repayment of debt acquired in acquisition
Investment in joint venture
Net cash used in investing activities
FINANCING ACTIVITIES:
Payment on settlement of warrants
Payment in connection with troubled debt restructuring
Proceeds from issuance of 2029 convertible senior notes
Payment of debt issuance costs
Payment related to contingent consideration
Purchase of capped call option
Principal payments for finance leases
Proceeds from issuance of common stock in connection with the exercise of options and ESPP
Repurchase of common stock
Net cash (used in) provided by financing activities

Effect of foreign exchange rate changes on cash and cash equivalents
Net decrease in cash, cash equivalents, and restricted cash
Cash classified within current assets held for sale
Cash, cash equivalents, and restricted cash - beginning of year
Cash, cash equivalents, and restricted cash - end of year
Supplemental disclosure of other cash flow information:
Cash paid for income taxes, net
Cash paid for interest
Supplemental disclosure of non-cash investing and financing activities:
Issuance of Second Lien Notes due 2029 in connection with troubled debt restructuring
Issuance of preferred stock in connection with troubled debt restructuring
Issuance of common stock in connection with troubled debt restructuring
e-bot7
Tenfold
VoiceBase
WildHealth
Total issuance of common stock in connection with troubled debt restructuring
Noncash Or Part Noncash Acquisition, Contingent Liability
e-bot7
Tenfold
VoiceBase
WildHealth
Purchase of property and equipment and intangible assets in accounts payable
Right-of-use assets obtained in exchange for operating lease liabilities
Right-of-use assets obtained in exchange for finance lease liabilities
Issuance of shares of common stock in connection with acquisition
Conversable Dec 13 2019
e-bot7
Tenfold
VoiceBase
Issuance of common shares as earn-out payment associated with business acquisitions
Issuance of shares of common stock to settle cash awards
Issuance of shares of common stock to settle cash awards (in shares)
Fair value of contingent earn-out recorded in other long-term liabilities
e-bot7
Tenfold
VoiceBase
Issuance of shares of common stock in connection with acquisition (in shares)
e-bot7
Tenfold
VoiceBase
WildHealth

Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets:
Cash and cash equivalents
Restricted cash

Comments